arrow
T

Thomas Danne

University of Colorado System
H指数:48
被引数:9,778

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring

关于连续血糖监测系统性能评估中透明度、标准化和校准校准的国际临床意见

2026-01-260
OAAI
Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial

抗胸腺细胞球蛋白在5~25岁近期发病的1型糖尿病3期患者中的最低有效低剂量(MELD-ATG):一项Ⅱ期、多中心、双盲、随机、安慰剂对照、适应性剂量范围试验

2025-09-180
PRE
Continuous Glucose Monitoring Metrics and Continuous Glucose Monitoring–Based Hypoglycemia; Including Duration; in Individuals with Type 1 Diabetes Switching to Once-Weekly Insulin Icodec: A Post Hoc Evaluation of ONWARDS 6

连续血糖监测指标和基于连续血糖监测的低血糖;包括持续时间;在从每周一次胰岛素icodec切换的1型糖尿病患者中:ONWARDS 6的事后评估

2025-07-180
PRE
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes

CVOT峰会报告2024:新的心血管、肾脏和代谢结局

2025-05-020
OA
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
2024-12-100
OAAI
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults

INNODIA 1型糖尿病自然史研究: 欧洲新诊断的儿童、青少年和成人队列

2024-03-225
OAAI
Validation of a risk prediction model for early chronic kidney disease in patients with type 2 diabetes: Data from the German/Austrian Diabetes Prospective Follow-up registry
2022-12-202
PRE